Ilika Plc Director Professor Sir William Wakeham Retires

Ilika plc

Ilika plc (LON:IKA), the advanced solid-state battery technology and materials innovation company, announced today that with effect from 30 September 2018, Professor Sir William Wakeham will be retiring from the board of the Company as a Non-Executive Director. Professor Sir William was appointed to the Board in May 2010 when the Company completed its IPO and he retires in line with the Company’s best practice governance guidelines.

Professor Sir William’s place on the board, the nomination, audit and remuneration committees will be filled by Jeremy Millard who is expected to be joining the board on 1 October and will be offering himself for election at the forthcoming AGM on 4 October 2018.

Jeremy has nearly 20 years investment banking experience and was previously a partner at Smith Square Partners LLC where he provided strategic and corporate advice to clients in the science, technology and telecommunications sectors, prior to which he headed up the technology practice at Rothschild in London. Jeremy is currently a Non-Executive Director and chairman of the audit committee of AIM-listed Idox plc as well as a Non-Executive Director of Blackbullion Limited.

Jeremy will be formally appointed to the Board following satisfactory completion of the customary due diligence for an AIM listed company’s board appointments. A further announcement confirming his appointment will be made once this process is completed and will include the disclosures required under Schedule 2(g) of the AIM Rules for Companies.

Mike Inglis, Chairman of Ilika Plc said: “The board would like to thank Bill for his service and the contribution he has made to the Company’s development during the past eight years. Bill’s technical and engineering experience has been key to the Company progressing the Stereax® battery technology.

“I would also like to welcome Jeremy to the board and expect to put his wealth of strategic advisory and corporate governance experience to good use in helping to develop Ilika as a business.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Dr Tom McColm on Ilika: Stereax revenues and Goliath milestones (LON:IKA)

Clean-tech equities specialist Dr Tom McColm reviews Ilika’s interim results, highlighting stable cash levels, the first recurring commercial revenues from Stereax, and continued technical and manufacturing progress on the Goliath battery platform.

Ilika CEO Graeme Purdy on Stereax and Goliath progress (LON:IKA)

Graeme Purdy, CEO of Ilika, outlines progress in manufacturing readiness and early customer shipments for the Stereax miniature solid-state battery, as well as ongoing grant-supported development and customer engagement for the Goliath EV battery programme.

Ilika moves into commercial phase with first Stereax electrode order

Ilika has received its first commercial order for Stereax battery electrodes, marking the start of scaled production for medical device applications.

Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video)

Ilika plc has crossed a commercial milestone with its first regular revenue stream from its Stereax battery line, according to Dr Tom McColm of Morphose Capital. With strong cash reserves, momentum on its Goliath platform, and growing interest from defence sectors, the next 12 months could be transformational.

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

Ilika CEO Graeme Purdy shares how the company has shifted from commissioning to customer deliveries of its Stereax batteries — and why its Goliath EV programme is designed to beat the commoditised market with faster charging and extended range.

Ilika reports on-track progress across Stereax and Goliath in H1 2025/26

Ilika reports unaudited half-year results to 31 October 2025, highlighting on-schedule delivery of key commercial milestones across its Stereax medical battery and Goliath EV battery programmes, alongside continued customer validation, pilot-line commissioning, and £4.2m fundraising to support its roadmap.

Search

Search